BIOLAN HEALTH takes over the presidency of the BASQUE HEALTH CLUSTER 14/06/2022 Corporate At the Basque Health Cluster Assembly held on 9 June, the renewal of the Board of Directors was approved, whose... Partners - Biolan
Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance th... 09/06/2022 Corporate Derek DiRocco of RA Capital Management and Olivier Litzka, PhD of Andera Partners Join Mineralys Board of Directors Partners - Ysios Capital Partners
GENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of... 09/06/2022 Corporate Last May 19th GENESIS Biomed received the award to the best biomedical consultancy of the XI Edition of the National... Partners - GENESIS Biomed
ORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Small... 08/06/2022 Healthcare Access to innovation Corporate Now has orphan drug designation for SCLC and AML Partners - Oryzon Genomics
Natac opens new Singapore office to locally serve its APAC customers 07/06/2022 Access to innovation International BioSpain Communication Corporate Madrid, Wednesday, June 1st, 2022— Natac has opened an office in central Singapore, to expand its sales, logistics and... Partners - Natac Group
ORYZON awarded EU Seal of Excellence and public financing of 2 M USD to develop iadademsta... 07/06/2022 Corporate Non-refundable funds from the Next Generation-EU program Partners - Oryzon Genomics
ORYZON to give updates on corporate progress in June 06/06/2022 Corporate Oryzon Genomics, S.A, announced today that its management will give an update on corporate progress at several... Partners - Oryzon Genomics
BIOLAN receives a new recognition for its innovate analytical digitalization solution at F... 02/06/2022 Agrifood Corporate BIOLAN was a finalist in the Agrobank Award, which recognizes the most innovative digitalisation solution, for its new... Partners - Biolan
Celtarys Research will present its technology for optimizing drug discovery at the XX Nati... 31/05/2022 Corporate With the title of "From early discovery to translational medicinal chemistry" the next meeting of the Spanish Society of... Partners - Celtarys Research
BCN HEALTH publishes a study evaluating the hospital incidence and medical costs of chroni... 30/05/2022 Healthcare Corporate BCN HEALTH has published the study ‘Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis... Partners - BCN Health
